Who needs to be screened for primary aldosteronism?
The prevalence of patients with primary aldosteronism (PA) is about 5%–15% in hypertensive patients, and it is common cause of secondary hypertension in clinical practice. Two major causes of PA are noted, namely bilateral adrenal hyperplasia and aldosterone-producing adenoma, and the general diagno...
Main Authors: | Wei-Chieh Huang, Feng-Hsuan Liu, Hao-Min Cheng, Yi-Chun Tsai, Yen-Ta Huang, Tai-Shuan Lai, Yen-Hung Lin, Vin-Cent Wu, Hsien-Li Kao, Charles Jia-Yin Hou, Kwan-Dun Wu, Szu-Tah Chen, Leay Kiaw Er |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-03-01
|
Series: | Journal of the Formosan Medical Association |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0929664623003352 |
Similar Items
-
Aldosterone-to-renin ratio (ARR) as a screening tool for primary aldosteronism (PA)
by: Chia-Hung Lin, et al.
Published: (2024-03-01) -
Who should be screened for primary aldosteronism? A comprehensive review of current evidence
by: Wei‐Chieh Huang, et al.
Published: (2022-09-01) -
How should anti-hypertensive medications be adjusted before screening for primary aldosteronism?
by: Jin-Ying Lu, et al.
Published: (2024-03-01) -
Taiwan mini-frontier of primary aldosteronism: Updating detection and diagnosis
by: Chin-Chen Chang, et al.
Published: (2021-01-01) -
Predictive performance of aldosterone-to-renin ratio in the diagnosis of primary aldosteronism in patients with resistant hypertension
by: Fabio Bioletto, et al.
Published: (2023-05-01)